Tezosentan in Pulmonary Arterial Hypertension
Clinical trial NCT01077297 · TERMINATED
Trial details
- NCT number
- NCT01077297
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2010-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.